IN VITRO REGULATION OF IMMUNOGLOBULIN SYNTHESIS AFTER MARROW TRANSPLANTATION. I: T-CELL AND B-CELL DEFICIENCIES IN PATIENTS WITH AND WITHOUT CHRONIC GRAFT-VERSUS-HOST DISEASELUM LG; SEIGNEURET MC; STORB RF et al.1981; BLOOD; ISSN 0006-4971; USA; DA. 1981; VOL. 58; NO 3; PP. 431-439; BIBL. 29 REF.Article

IN VITRO REGULATION OF IMMUNOGLOBULIN SYNTHESIS AFTER HUMAN MARROW TRANSPLANTATION. II: DEFICIENT T AND NON T LYMPHOCYTE FUNCTION WITHIN 3-4 MONTHS OF ALLOGENEIC, SYNGENEIC, OR AUTOLOGOUS MARROW GRAFTING FOR HEMATOLOGIC MALIGNANCYWITHERSPOON RP; LUM LG; STORB R et al.1982; BLOOD; ISSN 0006-4971; USA; DA. 1982; VOL. 59; NO 4; PP. 844-850; BIBL. 29 REF.Article

THE USE OF HEMOLYSIS-IN-GEL ASSAYS TO STUDY POLYCLONAL ANTIBODY SECRETION IN BONE MARROW TRANSPLANT RECIPIENTSRINGDEN O; WITHERSPOON RP; STORB R et al.1981; BLUT; ISSN 0006-5242; DEU; DA. 1981; VOL. 42; NO 4; PP. 221-226; ABS. GER; BIBL. 9 REF.Article

ASSOCIATION OF INTERSTITIAL PNEUMONIA AND DIMINISHED IN VITRO LYMPHOCYTE BLASTOGENESIS IN HUMAN MARROW GRAFT RECIPIENTSWITHERSPOON RP; STORB R; MICKELSON EM et al.1979; TRANSPLANTATION; USA; DA. 1979; VOL. 28; NO 5; PP. 412-414; BIBL. 13 REF.Article

IMMUNOGLOBULIN PRODUCTION OF DONOR ORIGIN AFTER MARROW TRANSPLANTATION FOR ACUTE LEUKEMIA OR APLASTIC ANEMIAWITHERSPOON RP; SCHANFIELD MS; STORB R et al.1978; TRANSPLANTATION; USA; DA. 1978; VOL. 26; NO 6; PP. 407-408; BIBL. 16 REF.Article

AUTOLOGOUS MARROW RECOVERY AND SENSITIZATION TO NON-HLA ANTIGENS AFTER HLA-IDENTICAL MARROW TRANSPLANTATION FOR APLASTIC ANEMIATSOI MS; WARREN RP; STORB R et al.1983; EXPERIMENTAL HEMATOLOGY; ISSN 0301-472X; USA; DA. 1983; VOL. 11; NO 1; PP. 73-81; BIBL. 36 REF.Article

CHRONIC GRAFT-VERSUS-HOST DISEASE IN 52 PATIENTS: ADVERSE NATURAL COURSE AND SUCCESSFUL TREATMENT WITH COMBINATION IMMUNOSUPPRESSIONSULLIVAN KM; SHULMAN HM; STORB R et al.1981; BLOOD; ISSN 0006-4971; USA; DA. 1981; VOL. 57; NO 2; PP. 267-276; BIBL. 47 REF.Article

TREATMENT OF HAIRY-CELL LEUKEMIA WITH CHEMORADIOTHERAPY AND IDENTICAL-TWIN BONE-MARROW TRANSPLANTATIONCHEEVER MA; FEFER A; GREENBERG PD et al.1982; N. ENGL. J. MED.; ISSN 0028-4793; USA; DA. 1982; VOL. 307; NO 8; PP. 479-481; BIBL. 20 REF.Article

IMMUNOLOGICAL RECOVERY IN 48 PATIENTS FOLLOWING SYNGENEIC MARROW TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCYWITHERSPOON RP; KOPECKY K; STORB RF et al.1982; TRANSPLANTATION; ISSN 0041-1337; USA; DA. 1982; VOL. 33; NO 2; PP. 143-149; BIBL. 26 REF.Article

PREDICTIVE FACTORS IN CHRONIC GRAFT-VERSUS-HOST DISEASE IN PATIENTS WITH APLASTIC ANEMIA TREATED BY MARROW TRANSPLANTATION FROM HLA-IDENTICAL SIBLINGSSTORB R; PRENTICE RL; SULLIVAN KM et al.1983; ANNALS OF INTERNAL MEDICINE; ISSN 0003-4819; USA; DA. 1983; VOL. 98; NO 4; PP. 461-466; BIBL. 40 REF.Article

MARROW TRANSPLANTATION WITH OR WITHOUT DONOR BUFFY COAT CELLS FOR 65 TRANSFUSED APLASTIC ANEMIA PATIENTSSTORB R; DONEY KC; THOMAS ED et al.1982; BLOOD; ISSN 0006-4971; USA; DA. 1982; VOL. 59; NO 2; PP. 236-246; BIBL. 68 REF.Article

GRAFT-VERSUS-HOST DISEASE AND SURVIVAL IN PATIENTS WITH APLASTIC ANEMIA TREATED BY MARROW GRAFTS FROM HLA-IDENTICAL SIBLINGS: BENEFICIAL EFFECT OF A PROTECTIVE ENVIRONMENTSTORB R; PRENTICE RL; BUCKNER D et al.1983; NEW ENGLAND JOURNAL OF MEDICINE; ISSN 0028-4793; USA; DA. 1983; VOL. 308; NO 6; PP. 302-307; BIBL. 27 REF.Article